RNA Clinical Trials Resources
-
The Evolving RNA Landscape: Navigating Science, Strategy, And Global Markets
10/27/2025
Learn how partnering with an experienced CRO can streamline development, reduce costs, and accelerate the delivery of RNA therapies to patients worldwide.
-
Five Questions Biotechs Should Ask Before Selecting A Bioanalytical CRO
9/2/2025
In a landscape where speed, quality, and trust are inseparable, choosing a CRO that shares your ambition is not optional; it is essential to survival and success.
-
Accelerating IND-Enabling Studies With Automated Bioanalysis Workflows
9/2/2025
Reimagined as automation-first, bioanalysis shifts from being an Investigational New Drug (IND) bottleneck to a catalyst for innovation—helping companies move therapies forward with greater confidence.
-
Why Bioanalysis Needs To Break Free From Manual Bottlenecks
9/2/2025
Bioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.
-
Navigating The Complexities Of Planning And Executing Multiregional Clinical Trials
8/27/2025
Plan your first overseas study or expand an established pipeline; with the help of strategic insights to navigate complexities, maximize investment, and position new therapies for international success.
-
Why New Zealand Is Emerging As A Clinical Trial Hub
8/27/2025
New Zealand is rapidly emerging as a premier destination for clinical research, offering a unique combination of regulatory agility, scientific expertise, and cost efficiency.
-
LBPs: Unique Quality, Manufacturing, And Nonclinical Considerations
8/14/2025
Live biotherapeutic products (LBPs) are emerging as a dynamic area of drug development, and their development demands tailored strategies that address both manufacturing and nonclinical complexities.
-
In-Vivo CAR Therapies — Global Research And Development Landscape
7/15/2025
Delve into the evolving in-vivo CAR therapy landscape, examining key technological innovations, major industry players, recent clinical progress, and regulatory developments.
-
How To Build Effective Clinical Trial Oversight And Leadership
7/14/2025
In a collaborative outsourcing model, the sponsor maintains direct contact with functional leads, eliminating communication gaps and enabling faster, better-informed decision-making.
-
Writing Effective Clinical Regulatory Documents For Therapy Trials
7/11/2025
Clinical medical writing for gene therapy regulatory documents is a demanding, detail-oriented task that diverges significantly from medical writing for more traditional therapies.